Wellcome Trust launches £200m start-up fund
UK-based health charity the Wellcome Trust has launched a ТЃ200m fund to invest in emerging biotechnology businesses.
The fund, temporarily called Project Sigma, will draw from the foundation's endowment and focus on long-term investments in small and medium-sized businesses in the UK and Europe.
It will run as a directly owned and managed business aiming for returns in line with the foundation's existing venture returns of around 17% annually.
Investors
The Wellcome Trust will be the sole provider of funding, however, other funders may co-invest alongside Sigma. Sigma plans to build a team of four to eight staff.
Investments
Sigma is expected to make individual investments of various sizes ranging from £100,000 to over £50m. It plans to take stakes of 20-100%.
People
Nigel Keen has been appointed chairman of Sigma and Martin Murphy is chief executive officer.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








